| Application no. and date | 04710081.3 (espacenet) (Federated) (European Patent Register), 20040211 | | Patent/reg. no. and date | DK/EP 1592423, 20110420 | | Publication date | 20051109 | | Priority no. and date | GB 0303289, 20030213, GB 0314100, 20030618, GB 0316184, 20030710, GB 0318311, 20030805 | | EP pub. no. and date |
EP 1592423 20051109 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | AST 100807-1XEP | | Inventor | Wedge, Stephen Robert,
c/o AstraZeneca R & D, Alderley,
Alderley Park
Macclesfield,
Cheshire SK10 4TG, GB,
Ryan, Anderson Joseph,
c/o Astrazeneca R & D, Alderley,
lderley Park
Macclesfield,
Cheshire SK10 4TG, GB | | Representative | | | Opponent | | | IPC Class | A61K 31/4745 (2006.01) , A61K 31/513 (2006.01) , A61K 31/517 (2006.01) , A61P 35/00 (2006.01) | | Title | Kombinationsterapi af ZD6474 med 5-FU og/eller CPT-11 | | Int. application no. | GB2004000550 | | Int. publication no. | WO2004071397 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
